<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">139</article-id>
      <article-id pub-id-type="doi">10.31348/2019/6/5</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Eyelid Edema as a First Sign of Lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Halička</surname>
            <given-names>Juraj</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0234-3616</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Žiak</surname>
            <given-names>Peter</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3910-6174</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jakubovičová</surname>
            <given-names>Božena</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Balhárek</surname>
            <given-names>Tomáš</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Plank</surname>
            <given-names>Lukáš</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Váleková</surname>
            <given-names>Ľubica</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Žiak</surname>
            <given-names>Dušan</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3910-6174</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Janurová</surname>
            <given-names>Katarína</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>10</day>
        <month>6</month>
        <year>2020</year>
      </pub-date>
      <issue>6</issue>
      <elocation-id>5</elocation-id>
      <abstract>
        <p>Chronic eyelid edema may be a symptom of different disease. The most common are autoimmune diseases such as orbital pseudotumor, vasculitis, sarcoidosis, or impaired vascular or lymphatic drainage. Rarely has it been reported as the sole manifestation of the lymphoma. Eyelid lymphoma is a special clinical entity in the spectrum of hematological malignancies. Here we present our clinical experience with eyelids lymphomas. First case is a 76-year-old female patient with bilateral edema of upper eyelid non-responding to anti-inflammatory therapy. Histological examination diagnosed mantle cells lymphoma. In the second case, 58-year-old patient was diagnosed with solitary unilateral tumor of the lower eyelid, where primary biopsy was ordered and diagnosis of MALT lymphoma was established after histological examination. In both cases, it was not solitary eyelid tumor, but systemic disease with multiple lymphadenopathy and bone marrow infiltration were found in follow-up examinations. Subsequently, patients care was given to the hemato-oncologist.</p>
      </abstract>
      <kwd-group>
        <kwd>eyelid edema</kwd>
        <kwd>B-lymphoma</kwd>
        <kwd>orbit</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R7431">
        <mixed-citation>Swerdlow, S.H., International Agency for Research on Cancer.: World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008: 1-439.</mixed-citation>
      </ref>
      <ref id="R7432">
        <mixed-citation>Freeman, C., Berg, J.W., Cutler, S.J.: Occurrence and prognosis of extranodal lymphomas. Cancer, 29; 1972: 252-260.</mixed-citation>
      </ref>
      <ref id="R7433">
        <mixed-citation>Sjo, L.D.: Ophthalmic lymphoma: epidemiology and pathogenesis. Acta ophthalmologica. 2009;87 Thesis 1:1-20.</mixed-citation>
      </ref>
      <ref id="R7434">
        <mixed-citation>Amin, M.B., Edge, S., Greene, F., et al.: AJCC cancer staging manual. 8th ed. Springer, New York, USA, 2017: 1-1024.</mixed-citation>
      </ref>
      <ref id="R7435">
        <mixed-citation>Svendsen, F.H., Rasmussen, P.K., Coupland, S.E. et al.: Lymphoma of the Eyelid - An International Multicenter Retrospective Study. Am J Ophthalmol, 177; 2017: 58-68.</mixed-citation>
      </ref>
      <ref id="R7436">
        <mixed-citation>Smith, L.B., Pynnonen, M.A., Flint, A., et al.: Progressive eyelid and facial swelling due to follicular lymphoma. Arch Ophthalmol., 127; 2009:1068-70.</mixed-citation>
      </ref>
      <ref id="R7437">
        <mixed-citation>Svendsen, F.H., Heegaard, S.: Lymphoma of the eyelid. Surv Ophthalmol, 62; 2017: 312-331.</mixed-citation>
      </ref>
      <ref id="R7438">
        <mixed-citation>McKelvie, P.A.: Ocular adnexal lymphomas: a review. Adv Anat Pathol, 17; 2010: 251-61.</mixed-citation>
      </ref>
      <ref id="R7439">
        <mixed-citation>Jakobiec, F.A.: Ocular adnexal lymphoid tumors: progress in need of clarification. American journal of ophthalmology, 145; 2008: 941-950.</mixed-citation>
      </ref>
      <ref id="R7440">
        <mixed-citation>Furdová, A., Oláh, Z.: Nádory oka a okolitých štruktúr. Brno, CERM, 2010, 152 s.</mixed-citation>
      </ref>
      <ref id="R7441">
        <mixed-citation>Krásný, J., Šach, J., Brunnerová, R., et al.: Orbitální tumory u dospělých – desetiletá studie. Čes. a slov. Oftal., 64; 2008: 219-227.</mixed-citation>
      </ref>
      <ref id="R7442">
        <mixed-citation>Furdová, A., Marková, A., Kapitánová, K ., et al.: Výsledky liečby pacientov s lymfómovým ochorením v oblasti očnice. Cesk Slov Oftalmol, 73; 2017: 211–217.</mixed-citation>
      </ref>
      <ref id="R7443">
        <mixed-citation>Jakobiec, F.A., Iwamoto, T., Patell, M., et al.: Ocular adnexal monoclonal lymphoid tumors with a favorable prognosis. Ophthalmology, 93; 1986: 1547-1557.</mixed-citation>
      </ref>
      <ref id="R7444">
        <mixed-citation>Vose, J.M.: Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. American Journal of Hematology, 87; 2012: 604–609.</mixed-citation>
      </ref>
      <ref id="R7445">
        <mixed-citation>Seregard, S., Milton, B.E.: Ocular Adnexal Lymphomas Five Case Presentations. Survey of ophthalmology, 47; 2002: 9-10.</mixed-citation>
      </ref>
      <ref id="R7446">
        <mixed-citation>Kirsch, L.S., Brownstein, S., Codere, F.: Immunoblastic T-cell lymphoma pre- senting as an eyelid tumor. Ophthalmology, 97; 1990: 1352-1357.</mixed-citation>
      </ref>
      <ref id="R7447">
        <mixed-citation>McNally, L., Jakobiec, F.A., Knowles, D.M.II.: Clinical, morphologic, immuno- phenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients. Am J Ophthalmol, 103; 1987: 555-568.</mixed-citation>
      </ref>
      <ref id="R7448">
        <mixed-citation>Yahalom. J., Illidge. T., Specht. L., et al.: International Lymphoma Radiation Oncology Group. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 92; 2015: 11-31.</mixed-citation>
      </ref>
      <ref id="R7449">
        <mixed-citation>Houghton, O., Gordon, K.: Abeloff‘s Clinical Oncology (Sixth Edition): Ocular Tumors, Elsevier, 2020: p 968-998.e9.</mixed-citation>
      </ref>
      <ref id="R7450">
        <mixed-citation>Zucca, E., Conconi, A., Martinelli., G., et al.: Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. J Clin Oncol., 35; 2017: 1905-1912.</mixed-citation>
      </ref>
      <ref id="R7451">
        <mixed-citation>Ganti, A.K., Bierman, P.J., Lynch, J.C., et al.: Hematopoietic stem cell transplantation in mantle cell lymphoma. Ann Oncol., 16; 2005: 618-24.</mixed-citation>
      </ref>
      <ref id="R7452">
        <mixed-citation>Ghielmini, M., Schmitz, S.F., Cogliatti, S., et al.: Swiss Group for Clinical Cancer Research. Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J Clin Oncol., 23; 2005: 705-11.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
